Vivos Therapeutics Raises $4.64M Through Warrant Exercise Amidst Financial Challenges
ByAinvest
Saturday, Jan 17, 2026 6:03 am ET1min read
VVOS--
Vivos Therapeutics (VVOS) has adjusted the exercise price of certain outstanding warrants, potentially raising $4.64 million. The company is issuing new unregistered warrants in a private placement, with varying expiration terms. Vivos Therapeutics operates in the healthcare sector, focusing on non-invasive solutions for sleep-disordered breathing. The transaction is expected to finalize around January 20, pending standard closing conditions.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet